1. Goldman L, Siddiqui EM, Khan A, et al. Understanding Acquired Brain Injury: A Review. Biomedicines. 2022;10:2167.

2. Deiner S, Baxter MG, Mincer JS, et al. Human plasma biomarker responses to inhalational general anaesthesia without surgery. Br J Anaesth. 2020;125:282−90.

3. Evered L, Silbert B, Scott DA, Zetterberg H, Blennow K. Association of changes in plasma neurofilament light and tau levels with anesthesia and surgery. JAMA Neurol. 2018;75:542e7.

4. Pham AT, Peterson RA, Slaughter S, Martin M, Hippensteel JA, Burnham EL, et al. Association of Central Nervous SystemRelated Biomarkers With Hospital Delirium in Patients With Respiratory Failure in the ICU. CHEST Crit Care. 2025;3:100143.

5. Xu M, Chen Y, Lin Y, Wang D, Zheng X. Serum-derived exosomal microRNAs as biomarkers for postoperative delirium. Front Neurosci. 2025;19:1525230.

6. Hoiland RL, Rikhraj KJK, Thiara S, et al. Neurologic prognostication after cardiac arrest using brain biomarkers: A systematic review and meta-analysis. JAMA Neurol. 2022;79:390−8.

7. Kaminska H, Kurek K, Zembala M, et al. The utility of brain bio-
markers in predicting survival and neurological outcomes in pediatric patients after cardiac arrest: A systematic review and meta-analysis. Cardiol J. 2025;32:130−41.

8. Moseby-Knappe M, Mattsson N, Nielsen N, Zetterberg H, Blennow K, Dankiewicz J, et al. Serum neurofilament light chain for prognosis of outcome after cardiac arrest. JAMA Neurol. 2019;76:64−71.

9. Walther J, Schmandt M, Muenster S, et al. The serum biomarkers NSE and S100B predict intracranial complications and in-hospital survival in patients undergoing veno-venous ECMO. Sci Rep. 2024;14(1):30545.

10. Hayhurst CJ, Patel MB, McNeil JB, et al. Association of neuronal repair biomarkers with delirium among survivors of critical illness. J Crit Care. 2020;4:94−9.

11. Astori V, Arruda BP, Marcarini PG, et al. Dexmedetomidine for preventing postoperative delirium in neurosurgical patients: a meta-analysis of randomized controlled trials. Braz J Anesthesiol. 2025;75:844662.

12. Diaz-Arrastia R, Wang KK, Papa L, et al. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma. 2014;31:19−25.

13. Rogan A, Sik A, Dickinson E. Endorsed by ACEM Emergency Department Epidemiology Network, et al Diagnostic performance of S100B as a rule-out test for intracranial pathology in head-injured patients presenting to the emergency department who meet NICE Head Injury Guideline criteria for CT-head scan. Emerg Med J. 2023;40:159−66.

14. Duda I, Wiorek A, Krzych
ºJ. Biomarkers Facilitate the Assessment of Prognosis in Critically Ill Patients with Primary Brain Injury: A Cohort Study. Int J Environ Res Public Health. 2020;17:4458.

15. Ito H, Ebihara T, Matsumoto H, Oda J. Relationship between growth differentiation factor 15 and functional prognosis and severity in traumatic brain injury. Sci Rep. 2025;15:2470.

16. Di Pietro V, Yakoub KM, Scarpa U, Di Pietro C, Belli A. MicroRNA Signature of Traumatic Brain Injury: From the Biomarker Discovery to the Point-of-Care. Front Neurol. 2018;9:429.

17. Sajanti A, Li Y, Hellstrom S, et al. Brain plasticity and neuroin- € flammatory protein biomarkers with circulating MicroRNAs as predictors of acute brain injury outcome - A prospective cohort study. J Neurol Sci. 2024;464:123169.

18. Hellstrom S, Sajanti A, Jhaveri A, et al. Diagnostic and prognos- € tic performance of urine ubiquitin carboxy-terminal hydrolase L1 across multiple acute brain injury types - A longitudinal prospective cohort study. Brain Spine. 2024;5:104173.

19. Johnson JJ, Loeffert AC, Stokes J, Olympia RP, Bramley H, Hicks SD. Association of salivary MicroRNA changes with prolonged concussion symptoms. JAMA Pediatr. 2018;172:65−73.

20. Paul JF, Ducroux C, Correia P, et al. Serum glial fibrillary acidic protein in acute stroke: feasibility to determine stroke-type, timeline and tissue-impact. Front Neurol. 2024;15:1470718.

21. Barba L, Vollmuth C, Halbgebauer S, et al. Prognostic serum biomarkers of synaptic, neuronal and glial injury in patients with acute ischemic stroke of the anterior circulation. Eur J Neurol. 2025;32:e16581.

22. Prus K, Rejdak K, Bilotta F. The Relationship Between Clinical Features of Ischemic Stroke and miRNA Expression in Stroke Patients: A Systematic Review. Neurol Int. 2025;17:55.

23. Chen ZJ, Han J. Mechanism of microRNA regulating apoptosis after reperfusion in patients with mechanical thrombectomy. J Physiol Pharmacol. 2024;75:145−57.

24. Sultan W, Machado LGDD, Ali MG, et al. MicroRNAs as biomarkers in spontaneous intracerebral hemorrhage: A systematic review of recent clinical evidence. Clin Neurol Neurosurg. 2022;213:107130.

25. Ryu JY, Zhang J, Tirado SR, et al. MiRNA expression profiling reveals a potential role of microRNA-148b-3p in cerebral vasospasm in subarachnoid hemorrhage. Sci Rep. 2024;14:22539.

26. Haarmann A, Vollmuth C, Kollikowski AM, et al. Vasoactive Soluble Endoglin: A Novel Biomarker Indicative of Reperfusion after Cerebral Large-Vessel Occlusion. Cells. 2023;12:288.

27. Scudellari A, Bilotta F. A pragmatic view on general anesthesia in mechanical thrombectomy for acute ischemic stroke. Braz J Anesthesiol. 2025;75:844599.

28. Goyal A, Failla MD, Niyonkuru C, Amin K, Fabio A, Berger RP, Wagner AK. S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury. J Neurotrauma. 2013;30:946−57.

29. Youn W, Yun M, Lee CJ, Scholl M. Cautions on utilizing plasma € GFAP level as a biomarker for reactive astrocytes in neurodegenerative diseases. Mol Neurodegener. 2025;20:54.

30. Condrat CE, Thompson DC, Barbu MG, et al. miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis. Cells. 2020;9:276.

31. Wagner AK, Amin KB, Niyonkuru C, et al. CSF Bcl-2 and cytochrome C temporal profiles in outcome prediction for adults with severe TBI. J Cereb Blood Flow Metab. 2011;31:1886−96.

32. Papa L, Brophy GM, Welch RD, et al. Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCHL1 in a large cohort of trauma patients with and without mild traumatic brain injury. JAMA Neurol. 2016;73:551−60.

33. Scholl M, Verberk IMW, Del Campo M, et al. Challenges in the € practical implementation of blood biomarkers for Alzheimer’s disease. Lancet Healthy Longev. 2024;5:100630.